The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms

Authors

H.A. Emsellem

Document Type

Journal Article

Publication Date

2003

Journal

Sleep

Volume

26

Issue

2

Inclusive Pages

131-135

Keywords

Neurology

This document is currently not available here.

Share

COinS